Metastatic Bone Disease

Introduction

Learning that cancer has spread to the bones can be a difficult moment. You may already be living with a cancer diagnosis, and now you are facing new symptoms — perhaps a deep, nagging bone pain, a fracture from a minor injury, or changes in how you walk or move. It is natural to feel worried about what this means for your day-to-day life, your independence, and the months and years ahead.

This guide is written for people who already know they have metastatic bone disease, or are being investigated for it, and want to understand what comes next. The good news is that bone metastases are one of the most actively treated areas in cancer care. A combination of systemic medicines, bone-protecting drugs, radiation, and — when needed — surgery can reduce pain, lower the chance of fractures, and help many people keep moving and doing the things that matter to them, often for a long time.

Metastatic bone disease, also called bone metastasis (or bone “mets”), is the term for cancer that has spread from its original site to one or more bones. The cancer cells in the bone are not bone cancer — they are cells from the original (primary) cancer, such as breast, prostate, lung, or kidney cancer, that have travelled through the bloodstream or lymph system and settled in bone tissue.

Healthy bone is constantly remodelling itself. Special cells called osteoclasts break down old bone, while osteoblasts build new bone. Cancer cells in the bone disturb this balance. Doctors often describe bone metastases in two patterns:

• Osteolytic (lytic): the cancer makes the bone thin and weak by breaking it down faster than it can be rebuilt. Lytic lesions are common in breast cancer, lung cancer, kidney cancer, and multiple myeloma.
• Osteoblastic (blastic): the cancer triggers extra bone formation, but the new bone is disorganised and weaker than normal. Blastic lesions are common in prostate cancer.
• Mixed: many cancers cause both patterns in different lesions.

The bones most often affected are the ones with the richest blood supply and the most bone marrow: the spine (especially the lower back and mid-back), the pelvis, the hips, the upper thigh bone (femur), the upper arm bone (humerus), the ribs, and the skull.

It is important to understand that metastatic bone disease is usually treated as part of a person’s overall cancer care. In most cases the goal is not to cure the bone metastasis itself but to control the cancer, protect the skeleton, relieve pain, and maintain quality of life — sometimes for many years.

Common Primary Cancers That Spread to Bone

Almost any cancer can spread to bone, but a small group accounts for the majority of cases. The pattern of bone involvement and the treatments used differ depending on the primary cancer.

• Breast cancer: bone is the most common site of distant spread. Lesions are often lytic or mixed, and many people live for years with treated bone disease.
• Prostate cancer: bone is by far the most common site of metastasis, and lesions are typically blastic. The spine, pelvis, and ribs are frequently involved.
• Lung cancer: bone metastases are common and tend to be lytic. They often cause significant pain.
• Kidney (renal cell) cancer: lesions are usually lytic and can be highly vascular (containing many blood vessels), which is important to know before surgery.
• Thyroid cancer: certain types, particularly follicular thyroid cancer, can spread to bone.
• Multiple myeloma: although not a solid tumour, myeloma is a cancer of plasma cells in the bone marrow and produces lytic bone lesions that behave similarly to bone metastases.

If your primary cancer is known, the treatment plan for bone disease will be shaped by it — the systemic drugs that work for the primary cancer are usually the same drugs that control the bone deposits.

Signs and Symptoms

If you already have a diagnosis, this section helps you recognise changes that may indicate progression of bone disease, a new site of involvement, or a complication that needs urgent attention.

Bone pain

Pain is the most common symptom. Cancer-related bone pain is often described as a deep, aching, or boring pain that does not go away with rest. It may be worse at night, may wake you from sleep, and may not respond fully to ordinary painkillers. Sudden, sharp pain on movement or weight-bearing — especially in a hip, thigh, or arm — can be a sign of a developing crack in the bone and should be reported to your team.

Fracture from a minor injury

A bone weakened by cancer can break under loads it would normally withstand — turning over in bed, stepping off a kerb, or lifting a bag. This is called a pathological fracture. Any sudden, severe pain after a small or no injury — especially in the hip, thigh, upper arm, or spine — needs medical assessment.

Spinal cord compression: an urgent warning

When a spinal metastasis presses on the spinal cord or the nerves leaving it, the result can be permanent loss of function if not treated quickly. Symptoms can include:

• New or worsening back or neck pain, especially that wakes you at night
• A band of pain or numbness around the chest or abdomen
• New weakness, heaviness, or unsteadiness in the legs
• New numbness or tingling in the legs or in the saddle area
• New difficulty controlling the bladder or bowels

High calcium in the blood (hypercalcaemia)

Extensive bone breakdown can release calcium into the bloodstream. Symptoms include increased thirst, frequent urination, nausea, constipation, tiredness, and confusion. Severe hypercalcaemia is a medical emergency.

Tiredness and low blood counts

If your team suspects new or progressing bone disease, they will combine imaging, blood tests, and sometimes a biopsy.

Imaging

• X-rays are often the first test and can show fractures, areas of bone loss, or new bone formation. They are useful but can miss early lesions.
• Bone scan (technetium scan) shows areas of increased bone activity across the whole skeleton and is widely used for screening, particularly in breast and prostate cancer.
• CT scan gives detailed pictures of bone structure and helps assess fracture risk and plan surgery or radiation.
• MRI is especially valuable for the spine, where it shows the spinal cord and nerve roots and detects compression early. It also shows the soft tissue around bone lesions.
• PET-CT (often with FDG, or in prostate cancer with PSMA tracers) can map cancer activity in the bone and elsewhere in the body. PSMA PET is now widely used in prostate cancer staging.

Blood tests

Tests may include calcium, kidney function, full blood count, alkaline phosphatase (a bone enzyme often raised in bone disease), and tumour markers specific to the primary cancer (such as PSA in prostate cancer).

Biopsy

When the primary cancer is known, imaging is often enough. A biopsy of a bone lesion may be performed when:

• The primary cancer has not yet been identified
• A single lesion is unusual or could be a different cancer
• Information about the tumour’s biology (hormone receptors, genetic changes) is needed to guide drug therapy

Biopsies are usually performed with a needle under CT guidance.

Assessing fracture risk

For a lesion in a long bone, doctors often use a clinical scoring system such as Mirels’ score, which considers the lesion’s location, size, appearance on X-ray, and the level of pain to estimate the risk of a future fracture. For the spine, the Spinal Instability Neoplastic Score (SINS) helps decide whether the affected vertebra is stable enough for radiation alone or whether surgical stabilisation is needed. These tools guide the team in deciding when to act preventively.

Treatment and Management

Treatment for metastatic bone disease is almost always multimodal — meaning several types of therapy work together. The plan is built by a multidisciplinary team that may include medical oncologists, radiation oncologists, orthopaedic oncologic surgeons, spine surgeons, pain specialists, palliative care physicians, and rehabilitation specialists.

Broadly, treatment has four goals:

1. Control the underlying cancer
2. Strengthen and protect the bones
3. Relieve pain and other symptoms
4. Prevent or treat “skeletal-related events” — fractures, spinal cord compression, and the need for radiation or surgery

Systemic cancer therapy

The mainstay of treatment is therapy directed at the underlying cancer. Because the bone deposits are made of cells from the primary cancer, treatments that control the primary cancer also tend to control the bone disease. Depending on the cancer type, this may include:

• Hormone therapy for hormone-sensitive breast and prostate cancers
• Targeted therapy for cancers with specific genetic changes, such as HER2-targeted drugs in breast cancer or EGFR/ALK inhibitors in lung cancer
• Chemotherapy in many cancer types, particularly when the disease is progressing on other treatments
• Immunotherapy in cancers such as lung cancer, kidney cancer, and melanoma
• Radionuclide therapy — intravenous radioactive medicines that target bone or specific cancer cells. Radium-223 is used in certain men with metastatic prostate cancer; lutetium-177-PSMA is used in selected prostate cancers; samarium-153 has been used for bone pain in some settings

The choice of systemic treatment is led by the medical oncologist and depends on the cancer type, previous treatments, the tumour’s molecular features, and your overall health.

Bone-targeted (bone-modifying) medicines

These drugs do not treat the cancer directly but strengthen the bones and reduce skeletal complications. Major oncology societies, including ASCO and ESMO, recommend that most patients with bone metastases from solid tumours, and patients with myeloma bone disease, are offered a bone-modifying agent unless there is a reason not to. The main options are:

• Bisphosphonates such as zoledronic acid (given by intravenous infusion, usually every 3 to 4 weeks, with the schedule sometimes lengthened to every 12 weeks after the first year). Pamidronate is another option.
• Denosumab, an injection under the skin given typically every 4 weeks. It works through a different mechanism (blocking the RANK ligand pathway).

Clinical trials have shown that these medicines reduce the rate of fractures and other skeletal-related events and can help with bone pain. Two important precautions apply:

• Dental health: both drugs carry a small risk of osteonecrosis of the jaw — a condition where part of the jaw bone fails to heal after dental procedures. A dental check-up before starting treatment, and good ongoing dental care, are important.
• Calcium and vitamin D: calcium levels can drop, especially with denosumab, so calcium and vitamin D supplements are usually advised, and blood calcium is monitored.

Radiation therapy

Radiation is one of the most effective treatments for cancer-related bone pain and for stabilising bones at risk. It is often given as:

• External beam radiation therapy (EBRT) to a painful site, sometimes as a single treatment (8 Gy in one fraction is a well-established option), or over several sessions. Most people notice pain relief within two to four weeks.
• Stereotactic body radiotherapy (SBRT), which delivers a very precise, high dose to a small area. SBRT is increasingly used for spinal metastases and for selected lesions when more durable local control is the aim.
• Post-operative radiation after surgical stabilisation, to control any remaining cancer cells in the treated bone.

Radiation can occasionally cause temporary worsening of pain (a “flare”) before it improves, fatigue, and skin changes in the treated area. Side effects depend on the body region treated.

Surgery

Surgery is considered when bones are broken or close to breaking, when there is spinal cord compression, when pain is severe and not controlled by other means, or when surgery offers a better and more durable solution than radiation alone. The aim is almost always to restore stability and function quickly, often as a single operation rather than a series. Common surgical options include:

Internal fixation of long bones

An intramedullary nail — a metal rod passed down the centre of a long bone such as the femur or humerus — protects the entire length of the bone from fracture. Plates and screws may be used in other locations. Internal fixation is often the right choice for an existing or impending fracture of the upper thigh or upper arm.

Joint replacement (endoprosthesis)

When a tumour has destroyed a large section of bone close to a joint — for example, the top of the femur near the hip — replacing the joint with a prosthesis (a hip replacement or a special tumour prosthesis) can restore function and allow weight-bearing soon after surgery.

Cement augmentation

Bone cement (polymethylmethacrylate) can be injected into a weakened area to strengthen it. It is often combined with internal fixation or used in vertebral procedures.

Vertebroplasty and kyphoplasty

These minimally invasive procedures inject cement into a collapsed or weakened vertebra through a needle, often providing rapid pain relief and structural support. Kyphoplasty additionally uses a small balloon to restore vertebral height before the cement is injected.

Spine decompression and stabilisation

When a spinal metastasis threatens or is already compressing the spinal cord, surgery may involve removing tumour tissue to free the cord (decompression) and securing the spine with rods and screws (instrumentation). For carefully selected patients, “separation surgery” creates a small gap between the tumour and the spinal cord so that stereotactic radiation can be safely delivered afterwards. The combined NOMS framework (Neurological, Oncological, Mechanical, Systemic) is often used by spine teams to decide between radiation, surgery, or a combination.

Pain management

Good pain control is part of treatment, not a sign of giving up. Pain relief usually combines:

• Paracetamol and anti-inflammatory medicines where appropriate
• Opioid medicines, used carefully and titrated by a pain or palliative care specialist
• Medicines for nerve pain such as gabapentin or pregabalin
• Steroids in specific situations, particularly when there is nerve compression
• Interventional techniques such as nerve blocks in selected cases

Pain specialists and palliative care teams are increasingly involved early in cancer care, not only at the end of life. Their input often makes a significant difference to comfort and function.

Hospital Stay, Recovery, and Rehabilitation After Surgery

If surgery is part of your treatment, the recovery experience depends on the type of operation, the bone treated, your overall health, and the underlying cancer.

Hospital stay

A typical stay after major bone or joint surgery is around three to seven days, though it can be shorter for minimally invasive spine procedures and longer for more complex operations. During the hospital stay, the team focuses on:

• Pain control
• Preventing blood clots in the legs (with leg compression devices and blood-thinning injections)
• Wound care
• Early movement out of bed, often within the first day or two
• Starting physiotherapy

Weight-bearing and physiotherapy

One of the advantages of modern bone stabilisation is that many people can put weight on the operated limb almost immediately, with the support of a frame or crutches and guidance from the physiotherapist. Early movement helps prevent muscle weakness, stiff joints, blood clots, and chest infections.

Typical recovery milestones

• First 1–2 weeks: wound healing, pain settling, gradual increase in walking and basic activities. Stitches or staples are usually removed during this period.
• 2–6 weeks: improving strength and confidence in movement, often outpatient physiotherapy. Many people notice considerable pain relief in the operated area as the bone is stabilised.
• 6–12 weeks: functional recovery; many patients return to most daily activities at a level matched to their overall cancer status.

Post-operative radiation may be planned to start once the wound has healed, usually two to four weeks after surgery. Systemic cancer therapy is usually resumed once the team agrees it is safe to do so.

Risks and Complications

Every treatment carries some risks. Your team will discuss these in the context of your individual situation.

Surgical risks

• Wound infection
• Bleeding (some bone metastases, especially from kidney cancer, are highly vascular and may need pre-operative interventions such as embolisation)
• Blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism)
• Implant problems, including loosening or failure over time
• Delayed wound healing, particularly if radiation has been given or is planned
• Anaesthesia-related risks
• Persistent or recurrent pain in some cases

Risks of radiation

• Skin irritation and fatigue
• A short-term pain flare before pain improves
• Effects specific to the area treated — for example, nausea after abdominal radiation, or temporary lowering of blood counts when large areas of marrow are treated

Risks of bone-modifying medicines

• Low calcium levels
• Kidney effects (particularly bisphosphonates)
• Osteonecrosis of the jaw — uncommon but important, hence the importance of dental review
• Atypical thigh bone fractures with very long use, in rare cases
• Flu-like symptoms after the first infusion of zoledronic acid in some people

Risks of systemic therapy

These depend on the specific drugs and are managed by the medical oncology team.

Monitoring and Follow-up

Once treatment is underway, monitoring continues for the rest of your cancer journey. Follow-up usually combines:

• Regular oncology clinic visits
• Imaging at intervals decided by your team — CT, MRI, bone scan, or PET, depending on the cancer type
• Blood tests, including calcium, kidney function, and tumour markers where relevant
• Review of any new pain or symptoms, which should be reported promptly rather than waiting for the next appointment
• Dental review during treatment with bone-modifying drugs

If you have had surgery with implants, additional X-rays may be done to check that the hardware is in place. If symptoms change — a new area of pain, weakness in a limb, new back pain, or any of the spinal cord compression warning signs — the team will arrange targeted imaging.

Living with Metastatic Bone Disease

For many people, metastatic bone disease becomes a long-term condition that is actively managed, much like other chronic conditions. The focus shifts from cure to control: keeping the disease quiet, protecting the skeleton, managing symptoms, and continuing to do the things that matter most.

Mobility and daily activities

A physiotherapist or rehabilitation specialist can help you find safe ways to stay active. Activity supports bone health, reduces stiffness, and helps with mood. The approach is usually low-impact: walking, swimming, stationary cycling, and gentle strengthening, adjusted for any bones at risk. Walking aids such as a stick, crutches, or a frame are not a defeat — they protect bones and conserve energy.

Falls prevention

Because weakened bones can fracture from a fall, reducing fall risk is important. Practical steps include:

• Removing loose rugs and tripping hazards at home
• Good lighting, especially on stairs and at night
• Sensible footwear
• A grab rail in the bathroom
• Reviewing medicines that can cause dizziness

Nutrition, calcium, and vitamin D

A balanced diet supports recovery and tolerance of treatment. Calcium and vitamin D intake matters, especially while on bone-modifying medicines. Your team can advise on supplements and check vitamin D levels.

Smoking, alcohol, and bone health

Stopping smoking helps wound healing after surgery and is good for the bones and the cancer outcome. Alcohol in excess affects bone strength and interacts with many medicines.

Emotional wellbeing

A diagnosis of bone metastasis often brings fear, sadness, and uncertainty — for the person diagnosed and for those close to them. Support can come from family, friends, oncology nurses, counsellors, palliative care teams, patient support groups, and faith communities. Speaking openly about symptoms and feelings often makes them easier to manage.

Work, travel, and planning ahead

Many people continue working in some form, sometimes with adjustments. Travel is usually possible between treatments, with a few precautions: a clear medication list, copies of recent imaging or summaries, and discussion with your team about anything specific to your bone disease (for example, very long flights and clot risk, or limits on lifting after surgery).

Outlook and Survival

The outlook with bone metastases varies widely. Some cancers, such as hormone-sensitive breast and prostate cancer, can be controlled for many years with bone involvement. Others progress more quickly. Survival depends on:

• The type and biology of the primary cancer
• Whether the cancer has spread only to bone or to other organs as well
• How the cancer responds to systemic treatment
• The number and location of bone lesions
• Your overall health and other medical conditions

Rather than focus on a single number, most clinicians describe outlook as a range and revisit it as the disease responds — or does not respond — to treatment. The most useful conversation about prognosis is one you have with your own oncologist, in the context of your specific cancer and how it is behaving.

What clinical experience shows clearly is that the right combination of treatments — systemic therapy, bone-modifying drugs, radiation, and selective surgery — can substantially reduce pain, prevent fractures, and preserve function, even when the underlying cancer cannot be cured.

Frequently Asked Questions

Does cancer in the bone mean the cancer is bone cancer?

No. The cells in the bone are cells from the original cancer (for example, breast or prostate cells) and are treated with therapies for that cancer. True “bone cancer” (primary bone cancer such as osteosarcoma) is uncommon and behaves differently.

Is metastatic bone disease curable?

In most adults, treatment aims to control the disease, relieve symptoms, and prevent complications, rather than cure. The exception is selected situations — for example, a single bone lesion in certain cancers — where more aggressive local treatment may be considered. Even when cure is not the goal, many people live well and for considerable lengths of time with treated bone metastases.

Will I definitely need surgery?

No. Many people are managed with systemic therapy, bone-modifying medicines, and radiation, without surgery. Surgery is considered when a bone is broken, is at high risk of breaking, or when there is spinal cord compression or pain that other treatments are not controlling.

How quickly does radiation relieve bone pain?

Many people notice improvement within two to four weeks, although some feel a temporary worsening of pain in the first few days. A single high-dose treatment can be as effective as a longer course for pain relief in many cases.

Why is dental review important before bone-modifying medicines?

Bisphosphonates and denosumab carry a small risk of osteonecrosis of the jaw, particularly after tooth extractions and other invasive dental procedures. Sorting out dental problems before starting these drugs, and maintaining good dental care during treatment, reduces this risk.

Can I take calcium and vitamin D supplements safely?

In most cases yes, and they are often advised while on bone-modifying treatment. Your team will check your blood calcium and vitamin D levels and guide the dose.

Is exercise safe with bone metastases?

In most cases yes, with guidance. A physiotherapist can suggest activities that are safe for your specific lesions and help you avoid high-impact movements or heavy lifting that could stress weakened bones. Activity helps with strength, mood, and overall function.

What if I develop sudden weakness in my legs or trouble passing urine?

Treat these as urgent symptoms. They can suggest spinal cord compression, where treatment within hours can preserve walking and bladder function. Go to an emergency department or contact your oncology team immediately.

Do children get metastatic bone disease?

Bone metastases in children are uncommon and usually occur with specific childhood cancers such as neuroblastoma. They are managed within paediatric oncology protocols and the approach differs from adult care. A paediatric oncology team should always lead the treatment.

How often will I be scanned during follow-up?

This depends on your cancer type, the treatments you are receiving, and how the disease is behaving. Your oncologist will set a schedule and adjust it based on symptoms and response to treatment.

Conclusion

Metastatic bone disease is a serious but actively treatable part of advanced cancer care. With a multidisciplinary plan that combines systemic cancer therapy, bone-modifying medicines, radiation, and surgery where it is needed, doctors today can often relieve pain, prevent fractures, treat spinal cord compression, and protect mobility — sometimes over many years.

The treatment that fits you depends on your primary cancer, the location and number of bone lesions, your overall health, and your own goals and preferences. Decisions are best made in conversation with an oncology team that knows your case, with a clear understanding of what each option is intended to achieve. Whatever the path, the focus throughout is the same: helping you live as well as possible, for as long as possible.